Using analog baselines to assess the effects of Naltrexone on self- injurious behavior

Research in Developmental Disabilities

Volumn 20, Issue 1, 1999, Pages 1-21

  Garcia, David ^a   Smith, Richard G ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLORAZEPATE DIPOTASSIUM; FLUOXETINE; NALTREXONE; OPIATE ANTAGONIST; PLACEBO; TRAZODONE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; AUTOMUTILATION; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MENTAL DEFICIENCY; ORAL DRUG ADMINISTRATION; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; PREDICTIVE VALUE OF TESTS; SELF-INJURIOUS BEHAVIOR; TREATMENT OUTCOME;

EID: 0032986261     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-4222(98)00028-6     Document Type: Article

References (30)

1. Aman M.G. Pharmacotherapy in the developmental disabilities New developments . Australia and New Zealand Journal of Developmental Disabilities. 17:1991;183-199.
2. Aman M.G. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities. Annals of Clinical Psychology. 5:1993;171-188.
3. Benjamin S.B., Seek A., Tresise L., Price E., Gagnon M. Case study Paradoxical response to naltrexone treatment of self-injurious behavior . Journal of the American Academy of Child and Adolescent Psychiatry. 34:1995;238-242.
4. Campbell M., Anderson L.T., Small A.M., Adams P., Gonzalez N.M., Ernst M. Naltrexone in autistic children Behavioral symptoms and attentional learning . Journal of the American Academy of Child and Adolescent Psychiatry. 36:1993;1283-1291.
5. Campbell M., Overall J.E., Small A.M., Sokol M.S., Spencer E.K., Adams P., Foltz R.L., Monti K.M., Perry R., Nobler M., Roberts E. Naltrexone in autistic children An acute open dose range tolerance trial . Journal of the American Academy of Child and Adolescent Psychiatry. 28:1989;200-206.
6. Carr E.G. The motivation of self-injurious behavior A review of some hypotheses . Psychological Bulletin. 84:1977;800-816.
7. Crews W.D., Bonaventura S., Rowe F.B. Cessation of long-term naltrexone therapy and self-injury A case study . Research in Developmental Disabilities. 14:1993;331-340.
8. Day R.M., Rea J.A., Schussler N.G., Larsen S.E., Johnson W.L. A functionally based approach to the treatment of self-injurious behavior. Behavior Modification. 12:1988;565-589.
9. Durand V.M., Carr E.G. Functional communication training to reduce challenging behavior Maintenance and application in new settings . Journal of Applied Behavior Analysis. 24:1991;251-264.
10. Herman B.H. A possible role of proopiomelanocortin peptides in self-injurious behavior. Progress in Neuro-Psychopharmacological and Biological Psychiatry. 14:(Suppl):1990;S109-S139.
11. Herman B.H., Hammock M.K., Arthur-Smith A., Kuehl K., Applegate K. Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children. Developmental Pharmacology and Therapeutics. 12:1989;81-89.
12. Iwata B.A., Dorsey M.F., Slifer K.J., Bauman K.E., Richman G.S. Toward a functional analysis of self-injury. Analysis and Intervention in Developmental Disabilities. 2:1982;3-20.
13. Iwata B.A. Functional analysis methodology Some closing comments . Journal of Applied Behavior Analysis. 27:1994;413-418.
14. Iwata B.A., Pace G.M., Dorsey M.F., Zarcone J.R., Vollmer T.R., Smith R.G., Rodgers T.A., Lerman D.C., Shore B.A., Mazaleski J.L., Goh H., Cowdery G.E., Kalsher M.J., McCosh K.C., Willis K.D. The functions of self-injurious behavior An experimental-epidemiological analysis . Journal of Applied Behavior Analysis. 27:1994;215-240.
15. Iwata B.A., Pace G.M., Kalsher M.J., Cowdery G.E., Cataldo M.F. Experimental analysis and extinction of self-injurious escape behavior. Journal of Applied Behavior Analysis. 23:1990;11-27.
16. Knabe R., Shulz P., Richard J. Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment. Journal of Autism and Developmental Disorders. 20:1990;591-593.
17. Mace F.C. The significance and future of functional analysis methodologies. Journal of Applied Behavior Analysis. 27:1994;385-392.
18. Mace F.C., Mauk J.E. Bio-behavioral diagnosis and treatment of self-injury. Mental Retardation and Developmental Disabilities Research Reviews. 1:1995;104-110.
19. Mello N.K., Mendelson H.H. Self-administration of an enkephalin analog by rhesus monkey. Pharmacology, Biochemistry and Behavior. 9:1978;579-586.
20. Northup J., Fusilier I., Swanson V., Roane H., Borrero J. An evaluation of methylphenidate as a potential establishing operation for some common classroom reinforcers. Journal of Applied Behavior Analysis. 30:1997;615-624.
21. Northup J., Jones K., Broussard C., DiGiovanni G., Herring M., Fusilier I., Hanchey A. A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate. Journal of Applied Behavior Analysis. 30:1997;121-125.
22. Northup J., Wacker D., Sasso G., Steege M., Cigrand K., Cook J., DeRaad A. A brief functional analysis of aggressive and alternative behavior in an outclinic setting. Journal of Applied Behavior Analysis. 24:1991;509-522.
23. Sandman C.A., Barron J.L., Colman H. An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior. American Journal on Mental Retardation. 95:1990;93-102.
24. Schaal D.W., Hackenberg T. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities. American Journal on Mental Retardation. 99:1994;123-140.
25. Smith S.G., Gupta K.K., Smith S.H. Effects of naltrexone on self-injury, stereotypy, and social behavior of adults with developmental disabilities. Journal of Developmental and Physical Disabilities. 7:1995;137-146.
26. Stoner G., Carey S.P., Ikeda M.J., Shinn M.R. The utility of curriculum- based measurement for evaluating the effects of Methylphenidate on academic performance. Journal of Applied Behavior Analysis. 27:1994;101-113.
27. Taylor D.V., Sandman C.A., Touchette P., Hetrick W.P., Barron J.L. Naltrexone improves learning and attention in self-injurious individuals with developmental disabilities. Journal of Developmental and Physical Disabilities. 5:1993;29-42.
28. Thompson T., Hackenberg T., Cerutti D., Baker D., Axtell S. Opioid antagonist effects on self-injury in adults with mental retardation Response form and location as determinants of medication effects . American Journal on Mental Retardation. 99:1994;85-102.
29. Vollmer T.R., Smith R.G. Some current themes in functional analysis research. Research in Developmental Disabilities. 17:1996;229-249.
30. Zingarelli G., Ellman G., Hom A., Wymore M., Heldorn S., Chicz-DeMet A. Clinical effects of naltrexone on autistic behavior. American Journal on Mental Retardation. 97:1992;57-63.